News & Updates
Find A Specialist
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
E. Mark Mahone, Ph.D., ABPP
Kennedy Krieger Institute
1750 East Fairmount Avenue
Baltimore, MD 21231
Phone: (443) 923-4442
Dr. Mark Mahone is a child neuropsychologist, research scientist, and the director of the Department of Neuropsychology at the Kennedy Krieger Institute. He is also professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine and is on the core faculty in psychology for the Maternal and Child Health Bureau (MCHB) Leadership Education Excellence in Caring for Children with Neurodevelopmental and Related Disabilities (LEND) Program and the Intellectual and Developmental Disabilities Research Center (IDDRC).
Dr. Mahone received his PhD from the State University of New York at Albany in 1990, and completed an APA-accredited internship in clinical psychology at the National Naval Medical Center in Bethesda, Maryland in 1991. After receiving his doctorate, Dr. Mahone completed a post-doctoral fellowship in pediatric neuropsychology at Boston Children's Hospital/Harvard Medical School Department of Psychiatry in 1993. Dr. Mahone is board-certified in clinical neuropsychology by the American Board of Professional Psychology and a licensed psychologist in Maryland. He the President-elect of the American Academy of Clinical Neuropsychology and is an editorial board member for six journals, including: Child Neuropsychology, Assessment, Developmental Neuropsychology, Archives of Clinical Neuropsychology, Journal of the International Neuropsychological Society, and The Clinical Neuropsychologist.
Dr. Mahone's research focuses on brain-behavior relationships in children with neurodevelopmental disorders as well as the development and validation (using neurobehavioral assessment and neuroimaging) of assessment methods to better characterize neurobehavioral development (and ultimately biomarkers) of these disorders. His work has included research in children with Attention-deficit/Hyperactivity Disorder (ADHD), movement disorders, learning disabilities, spina bifida, childhood cancer, prenatal alcohol exposure and sleep disorders.
He is currently Principal Investigator of an exploratory development grant (1R21 MH092693, "Frontostriatal Glutamate in ADHD: Neuropsychological and Behavioral Correlates"), which employs MR spectroscopy (obtained at 7.0 Tesla) in children ages 5-9 years, and a research grant (1R01 HD068425, "Development of ADHD in Preschool Children: Neuroimaging and Behavioral Correlates"), which uses brain mapping and neurobehavioral assessment to characterize the development of preschool children identified as at risk for ADHD.
- Typically developing boys, ages 9-14/grades 4-8
- Children, ages 5-9 years, with or without ADHD
- Children, ages 4-5 years, with or without ADHD
- Parents of children who have been diagnosed with ADHD